Autonomix Medical (NASDAQ:AMIX) Releases Quarterly Earnings Results, Beats Estimates By $1.38 EPS

Autonomix Medical (NASDAQ:AMIX) issued its quarterly earnings results on Wednesday. The company reported ($5.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($6.40) by $1.38, FiscalAI reports.

Autonomix Medical Stock Down 3.0%

Shares of AMIX stock opened at $6.66 on Friday. The company’s fifty day simple moving average is $6.83 and its two-hundred day simple moving average is $7.74. Autonomix Medical has a 52 week low of $2.44 and a 52 week high of $32.55. The stock has a market cap of $6.46 million, a P/E ratio of -0.09 and a beta of -1.17.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on AMIX shares. Zacks Research raised Autonomix Medical to a “hold” rating in a research report on Tuesday, June 2nd. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.